T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.6B |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$1.1B |
| 3 |
Elevance Health
ELV
|
+$903M |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$873M |
| 5 |
Medtronic
MDT
|
+$868M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.89B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.06B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$946M |
| 4 |
Aptiv
APTV
|
+$886M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$662M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.57% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.16% |
| 4 | Industrials | 12.02% |
| 5 | Technology | 10.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DXYN
1251
DELISTED
Dixie Group Inc
DXYN
| $13.2M | ﹤0.01% |
1,458,820
+100
| +0% | +$878 |
|
1252
Ralph Lauren
RL
$23.2B
| $13.2M | ﹤0.01% |
100,150
-46,429
| -32% | -$6.87M |
|
|
PRO
1253
DELISTED
PROS Holdings
PRO
| $13.1M | ﹤0.01% |
530,180
-924,420
| -64% | -$22.8M |
|
|
FDO
1254
DELISTED
FAMILY DOLLAR STORES
FDO
| $13.1M | ﹤0.01% |
165,083
+3,294
| +2% | +$257K |
|
1255
Sixth Street Specialty
TSLX
$1.79B
| $13.1M | ﹤0.01% |
759,040
-39,500
| -5% | -$694K |
|
|
SHLO
1256
DELISTED
Shiloh Industries Inc
SHLO
| $13M | ﹤0.01% |
927,936
-309,558
| -25% | -$4.13M |
|
|
ARRS
1257
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $13M | ﹤0.01% |
450,014
+129,600
| +40% | +$3.69M |
|
1258
Comscore
SCOR
$90.4M
| $12.9M | ﹤0.01% |
12,610
+8,530
| +209% | +$8.03M |
|
1259
Goodyear
GT
$1.76B
| $12.9M | ﹤0.01% |
476,676
+10,280
| +2% | +$269K |
|
1260
Supernus Pharmaceuticals
SUPN
$2.78B
| $12.8M | ﹤0.01% |
1,061,450
-360,382
| -25% | -$3.41M |
|
1261
Hormel Foods
HRL
$13.5B
| $12.8M | ﹤0.01% |
449,496
+800
| +0.2% | +$21.9K |
|
|
CATM
1262
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $12.8M | ﹤0.01% |
339,494
-11,000
| -3% | -$405K |
|
|
ZINC
1263
DELISTED
HORSEHEAD HLDG CORP COM STK (DE)
ZINC
| $12.8M | ﹤0.01% |
1,007,830
+153,130
| +18% | +$2.08M |
|
|
CDK
1264
DELISTED
CDK Global, Inc.
CDK
| $12.7M | ﹤0.01% |
271,754
+1,486
| +0.5% | +$67.8K |
|
1265
Pinnacle West Capital
PNW
$12.3B
| $12.6M | ﹤0.01% |
197,780
+5,000
| +3% | +$334K |
|
1266
Infosys
INFY
$49.1B
| $12.5M | ﹤0.01% |
1,420,988
-219,180
| -13% | -$1.93M |
|
1267
Accuray
ARAY
$32.5M
| $12.5M | ﹤0.01% |
1,339,170
+14,170
| +1% | +$113K |
|
1268
Clarus
CLAR
$141M
| $12.5M | ﹤0.01% |
1,323,477
-70,451
| -5% | -$528K |
|
|
FCH
1269
DELISTED
Felcor Lodging Trust
FCH
| $12.5M | ﹤0.01% |
1,083,648
+75,800
| +8% | +$816K |
|
|
POM
1270
DELISTED
PEPCO HOLDINGS, INC.
POM
| $12.4M | ﹤0.01% |
461,200
+25,800
| +6% | +$700K |
|
1271
Boot Barn
BOOT
$4.96B
| $12.4M | ﹤0.01% |
517,230
+267,130
| +107% | +$5.96M |
|
|
NWHM
1272
DELISTED
THE NEW HOME COMPANY INC.
NWHM
| $12.3M | ﹤0.01% |
772,670
-251,053
| -25% | -$3.6M |
|
|
BIG
1273
DELISTED
Big Lots, Inc.
BIG
| $12.3M | ﹤0.01% |
255,900
+88,400
| +53% | +$4.17M |
|
|
CPHD
1274
DELISTED
Cepheid Inc
CPHD
| $12.2M | ﹤0.01% |
215,064
+23,797
| +12% | +$1.34M |
|
|
DRII
1275
DELISTED
DIAMOND RESORTS INTL, INC
DRII
| $12.2M | ﹤0.01% |
+365,300
| New | +$11.5M |
|
Similar funds
T. Rowe Price Associates's Q1 2015 Portfolio in Review
As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
- T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
- T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
- T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
- T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.
Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.